Bacterial Therapy: Modulation of the Microbiome With Dr. Bernat Olle
Business Of Biotech
00:00
The Next Big Step for Vidanta
The next step for us really is proving the modality to the outside world with patient data in randomized well-controlled reasonable size studies. We have shown that we can scale their manufacture and do it at GMP grade at least up to phase two scale for now. And we've also shown that if you give this this type of drugs to healthy volunteers, we've those about 140 healthy volunteers I think across three studies. Then we can do that very safely and then we can find those and those regimens that optimize their colonization.
Play episode from 39:07
Transcript
